Protein S and anti-protein S antibodies among Egyptian patients with systemic lupus erythematosus

Antiphospholipid antibodies in Egyptian systemic lupus erythematosus patients

Anti-nucleosome antibodies and systemic lupus erythematosus

Serum level of tumour necrosis factor–alpha in Egyptian patients with systemic sclerosis and systemic lupus erythematosus : Correlation with various disease parameters

Detection of Anti-cyclic citrullinated peptides antibodies in the sera of patients with systemic lupus erythromatosus :Association with clinical and laboratory parameters of the disease

Types, outcomes and prevalence of viral, fungal and parasitic infections in Egyptian systemic lupus erythematosus patients

Anti-topoisomerase-I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus

BAFF promoter polymorphisms in Egyptian patients with systemic lupus erythematosus

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

Evalueation of anti-beta2-glycoprotein I antibodies and anticardiolipin antibodies in patients with systemic lupus erythematosis